Zobrazeno 1 - 10
of 20
pro vyhledávání: '"T. A. Sveklina"'
Autor:
T. A. Sveklina, V. N. Krupin
Publikováno v:
Vestnik Urologii, Vol 0, Iss 1, Pp 3-7 (2013)
The article represents the study of survival rate (common, oncology-specific, disease-free) and frequency and nature of the recurrence after organ-saving surgery of patients with muscleinvasive bladder cancer stages T2b and T3aN0M0G1-G3 with full dia
Externí odkaz:
https://doaj.org/article/f1594eb086b540139f6d4f6bc4179241
Autor:
T. S. Sveklina, S. B. Shustov, S. N. Kolyubayeva, A. N. Kuchmin, V. A. Kozlov, E. V. Smirnova, A. V. Zharkov
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 15-24 (2024)
BACKGROUND: Half of all patients with chronic heart failure (CHF) have preserved ejection fraction (CHF-nEF). The drug’s use effective for treatment of CHF with reduced ejection fraction (CHF-nFV) reduces the hospitalization incidence but does not
Externí odkaz:
https://doaj.org/article/798f78781ea749169fbb80e4e3481e66
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 76-80 (2023)
The review outlines modern concepts of the relevance of fixed-dose combination therapy comprising angiotensin-converting enzyme inhibitor and dihydropyridine calcium channel antagonist as an antihypertensive component with the HMG-CoA reductase inhib
Externí odkaz:
https://doaj.org/article/7f5e1611256340d8adfa5d612c9bacab
Autor:
T. S. Sveklina, S. B. Shustov, S. N. Kolyubayeva, A. N. Kuchmin, V. A. Kozlov, O. A. Miroshnichenko
Publikováno v:
Сахарный диабет, Vol 26, Iss 4, Pp 304-310 (2023)
BACKGROUND. Patients with type 2 diabetes mellitus (DM2) have disorders of cellular and plasma hemostasis independent of the level of glycemia, increased platelet activation, combined with microvascular angiopathy. The study of the role of genetic ma
Externí odkaz:
https://doaj.org/article/a9a8d1b79227449a95f8a89867342731
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 27:653-661
Objective. To determine the presence or absence of the effect of therapy with renin-angiotensin-aldosterone system (RAAS) blockers in patients with COVID-19.Design and methods. We examined 57 patients who were treated in a medical unit at the FGAU CE
Publikováno v:
Genes & Cells. 16:14-21
The review presents data on the importance of mitochondrial DNA in aging of cardiomocytes. The mechanisms of accumulation of mutations in mtDNA and reduction of its content, as well as the consequences of these phenomena in cardiomyocytes are describ
Autor:
A. N. Kuchmin, V. V. Ekimov, D. A. Galaktionov, I. M. Borisov, A. A. Sheveliov, T. S. Sveklina
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 27:530-535
Background. Obstructive sleep apnea (OSA) is frequently associated with hypertension (HTN), and about 50 % hypertensive patients have concomitant OSA. Episodes of transient upper airway obstruction affect the daily blood pressure profile, leading to
Autor:
S. N Kolyubaeva, A. A Kondratenko, K. Alkhazhe, E. V Kryukov, V. A Kachnov, R. I Glushakov, T. S Sveklina, L. A Myakoshina, M. S Tyuryupov, E. G Neronova, M. I Eliseeva
Publikováno v:
Genes & Cells. 16:86-90
The work analyzed the polymorphisms of the HLA-DRB1 and IL28 genes in 100 patients who underwent COVID-19 with the development of infection with varying degrees of severity. To a mild degree of severity were patients without complications in the form
Autor:
M. I. Volkova, A. S. Kalpinskiy, P. S. Borisov, O. I. Evsyukova, A. S. Olshanskaya, V. B. Matveev, B. Ya. Alekseev, E. V. Peganova, A. F. Nasretdinov, E. V. Lymar, E. G. Ovchinnikova, T. A. Sveklina, E. A. Usynin, A. M. Abdelgafur, E. A. Tararova, L. M. Shumova, A. S. Belenkov, I. Yu. Dolgov, N. G. Ponomareva, I. V. Evstigneeva, A. N. Ivanov, A. R. Isaev, R. V. Leonenkov, A. V. Meskikh, M. R. Mukhitova, S. A. Orlova, I. V. Teslenok, M. M. Shegurova, M. T. Aivazov, Z. V. Amoev, K. G. Babina, A. A. Vorontsova, E. V. Karabina, N. V. Kirdakova, I. E. Shumskaya, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, E. S. Lyutova, M. M. Fael, A. N Chugarova, A. S. Antipin
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 31-44 (2021)
Objective. The primary endpoint was progression-free survival; secondary endpoints included overall survival, objective response rate and duration, tumor control rate and duration, as well as safety profile of lenvatinib with everolimus in consecutiv
Publikováno v:
Bulletin of the Russian Military Medical Academy. 22:53-58
Comparative analysis of laboratory data of 46 patients suffering from pneumonia caused by SARS-CoV-2 and 12 patients - pneumonia of bacterial etiology is given. It was established that in patients with COVID-19 compared to patients with bacterial pne